Supplementing alpha-tocopherol (vitamin E) and vitamin D3 in high fat diet decrease IL-6 production in murine epididymal adipose tissue and 3T3-L1 adipocytes following LPS stimulation

The incidence of obesity has dramatically increased during the past several decades [1]. In 2006, the World Health Organization estimated that 1.6 billion adults worldwide were overweight and 400 million adults were obese [2]. Although morbidly obese people have a greater food intake than non-obese people, they may suffer from nutritional deficiencies.

High fat diets (HFDs) contribute to the accumulation of adipose tissue, resulting in obesity and possibly insulin resistance. Adipose tissue secretes soluble factors called adipokines, which include pro-inflammatory cytokines. It is known that long-term low systemic inflammation that occurs in obese individuals contributes to the development of metabolic syndrome [3]. Lira et al. [4] reported that body fat correlates with cytokine levels, and it was demonstrated that increased body fat was associated with elevated cytokine levels in obese adolescents. Tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), which are increased in obese subjects, may downregulate adiponectin production. In contrast, adiponectin reduces the production and activity of TNF-α and IL-6. IL-6 is considered the major inflammatory mediator in obesity. IL-6 has been implicated in the release of triglycerides and free fatty acids, downregulated lipoprotein lipase, insulin resistance, increased production of reactive oxygen species and decreased nitric oxide generation [5].

IL-10, which is an anti-inflammatory cytokine, may antagonize the actions of IL-6 [5]. Recently, Hong et al. (2010) demonstrated that IL-10 increases insulin sensitivity, protects from obesity-associated macrophage infiltration, prevents increases in proinflammatory cytokines and may prevent the deleterious actions of pro-inflammatory cytokines on insulin signaling and glucose metabolism [6].

Obesity is associated with vitamin deficiencies. Low concentrations of 25-hydroxyvitamin D3 have been associated with an increased risk of diabetes and other cardiovascular disease risk factors [7]. In patients with metabolic syndrome, six weeks of alpha-tocopherol supplementation reduced serum levels of TNF-α [8].

Antioxidant micronutrients have been proposed as adjunctive therapy in patients with diabetes [9]. Indeed, some minerals and vitamins are able to participate indirectly in the reduction of oxidative stress in diabetic patients by improving glycemic control and/or exerting antioxidant activity. For example, Foss [10] speculated that vitamin D deficiency is the cause of obesity, which can be reversed by improving the levels of vitamin D. On the contrary, Czernichow and colleagues [11] demonstrated that the incidence of metabolic syndrome was reduced in healthy individuals that were given an anti-oxidant formula containing vitamin E, vitamin C, beta-carotene, zinc and selenium.

Our hypothesis is that the well established proinflammatory effect of HFD ingestion on white adipose tissue could be reduced by supplementation of vitamin D3 and alpha-tocopherol (vitamin E). The aim of this study was to examine the effects of vitamins D3 and E supplementation on the levels of IL-6 and IL-10 protein expression in adipose tissue of mice provided with a HFD. Additionally, we evaluated the effects of vitamin E and vitamin D3 on 3T3-L1 adipocytes stimulated with LPS in terms of IL-6 and IL-10 secretion.

The Experimental Research Committee of the São Paulo Federal University approved all procedures for the care of the animals used in this study (protocol n°2007/0388). Thirty-day-old male Swiss mice were used in this study and were kept under controlled conditions (12 h light: 12 h dark cycle with lights on at 07:00; 22°C ± 1°C). During the experimental period, the animals were group-housed and provided water and a specific diet ad libitum. The animals were treated for eight weeks as follows: 1) HFD - Twelve animals were treated for eight weeks with a hyperlipidic diet based on the AIN93 formulation with 20% of the fat from soya beans; 2) HFD Vitamin D3 - Twelve animals were treated for four weeks with a hyperlipidic diet based on the AIN93 formulation with 20% of the fat from soya beans and an additional four weeks with the same diet supplemented with 1,25(OH)₂ vitamin D3 (0.05 mg/Kg of diet); and 3) HFD Vitamin E - Twelve animals were treated for four weeks with a hyperlipidic diet based on the AIN93 formulation with 20% of the fat from soya beans and an additional four weeks with the same diet supplemented with alpha-tocopherol (0.9 g/kg of diet). The animals' weight and food intake were evaluated weekly.

Supplementation of vitamin D3 and vitamin E reduced proinflammatory cytokine production by the WAT from the HFD-fed mice. In the 3T3-L1 adipocytes, LPS stimulated IL-6 and IL-10 production. Addition of vitamins D3 and E in the culture medium with LPS significantly reduced IL-6 levels without altering IL-10 levels. These results suggest the importance of vitamins, both in vivo and in vitro, in controlling the inflammatory state in adipocytes.

Obesity occurs due to a complex combination of multiple environmental and genetic factors. Consumption of highly energetic, fatty, and palatable foods is the most important epidemiological predisposing factors to obesity development [12, 13]. Studies have shown that the increase in the production of adipokines, such as PAI-1 [14], TNF-α [15] and IL-6, [16], and the reduction of adiponectin [17] are critically involved in the pathogenesis of obesity.

HFD causes lipotoxic impairment of insulin action and the regulatory mechanisms of body weight [18]. Mice fed with HFD supplemented with vitamin E and vitamin D3 had a slight gain in body weight without changes in the adiposity index and energy intake, which suggested an increase in thermogenesis and metabolic rate.

Several studies have shown an inverse association of serum vitamin D3 levels with adiposity and body mass index [19–22]. In addition, it has been demonstrated that blockade of 3T3-L1 cell differentiation by vitamin D3 involves C/EBPβ suppression, PPARγ upregulation, and antagonist function of PPARγ activity [23, 24].

However, Wong et al. [22] demonstrated that vitamin D receptor-null mice have a higher rate of fatty acid beta-oxidation and an up regulation of uncoupling protein (UCP) 1, UCP2 and UCP3 expression in the WAT. They also demonstrated that 1,25-dihydroxyvitamin D3 directly suppressed the expression of the UCPs in primary brown fat culture. They concluded that vitamin D3 is involved in energy metabolism and adipocyte biology in vivo in part through regulation of beta-oxidation and UCP expression. The difference between this study and the present study may be due to differences in the protocols that were used.

Furthermore, Sun and Zemel [23] showed that calcitriol increased production of reactive oxygen species (ROS) by inhibiting UCP2 expression and stimulating intracellular calcium influx, resulting in fatty acid synthesis and lipolysis inhibition. However, Zembel and Sun [24] suggested that calcitriol exerts a dose-dependent impact on adipocyte apoptosis, indicating that a low physiological dose inhibits apoptosis and a pharmacological dose stimulates apoptosis. More studies are necessary to understand the effects of HFD with vitamin D3 and vitamin E supplementation on body weight gain and thermogenesis.

The effect of vitamin E supplementation on body mass index is not conclusive. Botella-Carretero and colleagues [25] demonstrated an inverse correlation between vitamin E and body mass index, whereas other studies have reported no correlation [26, 27].

Obesity and insulin resistance are associated with low grade chronic systemic inflammation [28]. In models of diet-induced obesity and genetic obesity, the adipose tissue has increased expression of proinflammatory cytokines, such as TNF-α, IL-1, and IL-6 [15, 29]. Furthermore, fatty acids increased IL-6 serum concentration and gene expression in adipocytes [30], and a saturated fat-rich diet increased IL-6 concentrations in human adipocytes [31]. The main result of our study is that treatment with vitamin D3 and vitamin E reduces IL-6 levels in epididymal adipose tissue (in vivo) and 3T3-L1 adipocytes (in vitro).

Low concentrations of vitamin D is the most common vitamin deficiency associated with obesity and may be closely linked to the increase in ROS which activates the inflammatory pathway [7]. There is evidence that insulin resistance results from the proinflammatory cytokines actions released from the adipose tissue, such as TNF-α and IL-6 [32].

Production of IL-6 increases with adiposity, and circulating IL-6 concentrations are highly correlated with percentage of body fat and insulin resistance [33]. Vitamin E supplementation in patients with diabetes decreases the levels of proinflammatory cytokines, such as IL-1, TNF-α, IL-6, and reactive C protein, in serum and stimulated monocytes [34, 35]. In addition, high intake of foods rich in vitamin E demonstrated an inverse correlation with levels of C reactive protein and IL-6 [36]. Elevated TNF-α concentrations cause stress oxidation in monocytes which, conversely, increases low density lipoprotein (LDL) oxidation [37]. Oxidative modification of lipoproteins is an essential component of the atherogenic process [34]. Manning et al. (2004) showed that vitamin E supplementation decreased plasma peroxide concentration in obese individuals [26]. In the present study, we demonstrated that a vitamin D3- and vitamin E-supplemented diet decreases IL-6 levels in adipose tissue and in 3T3-L1 adipocytes. Taken together, these results demonstrate that vitamin E and vitamin D3 could have a direct effect on adipocytes.

In conclusion, vitamin D3 and vitamin E supplementation in HFD had an anti-inflammatory effect by decreasing IL-6 production in epididymal adipose tissue in mice and in 3T3-L1 adipocytes stimulated with LPS. Potentially, our results suggest that vitamin E and D3 supplementation can be used as an adjunctive therapy to reduce proinflammatory cytokines levels in obese patients.